Aller au contenu principal
Accès ouvert déclaré 2026 conference-abstract

P289 - ECE_1810 - Differential skeletal recovery after surgical vs medical remission in Cushing’s disease: a 5-year observational study

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : it. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Background Skeletal fragility is a major and often irreversible complication of Cushing’s disease (CD). Although remission of hypercortisolism may allow partial bone recovery, long-term data comparing surgical and medical remission are scarce. In particular, whether sustained eucortisolism achieved through medical therapy results in skeletal recovery comparable to surgical cure remains unresolved. Methods We conducted a 5-year retro-prospective observational study including 58 patients with CD and sustained normalization of 24-h urinary free cortisol (UFC), achieved after transsphenoidal surgery (surgical remission, n = 36) or during long-term medical therapy (medical remission, n = 22). Baseline assessment was performed during active disease. Endocrine, metabolic and skeletal evaluations, including DXA-derived bone mineral density (BMD) and fragility fracture assessment, were performed at 2 and 5 years after first UFC normalization. A complete 5-year follow-up was available in 33 patients (22 surgical, 11 medical). Results At baseline, patients were comparable for age and biochemical severity, whereas disease duration before UFC normalization was significantly longer in medically treated patients (12 vs 1 months, P = .001). Lumbar spine BMD significantly increased in the overall cohort at 2 years (0.863 vs 0.830 g/cm², P = .018) and further at 5 years (0.960 vs 0.830 g/cm², P = .001). This improvement was robust and consistent in surgically cured patients at both 2 (P = .039) and 5 years (P = .002), while only a non-significant trend was observed in the medical remission group. No significant changes were detected at femoral neck or total hip in either group. The prevalence of densitometric osteoporosis decreased from 68% at baseline to 57% at 5 years. Despite biochemical remission, incident fragility fractures occurred during follow-up (3 at 2 years and 3 at 5 years). In multivariate regression analysis adjusted for age, sex, disease duration and baseline UFC, baseline lumbar spine BMD emerged as the only independent predictor of 5-year lumbar spine BMD (β = .573, P = .002). Conclusions In Cushing’s disease, long-term skeletal recovery remains incomplete and strongly site-specific, predominantly affecting trabecular bone. Surgical remission is associated with a significantly greater lumbar spine BMD recovery compared with medical remission, despite sustained UFC normalization in both groups. Persistent fracture occurrence indicates that biochemical control alone does not fully restore skeletal integrity. Early diagnosis and baseline bone status critically determine long-term bone outcomes, supporting the need for prolonged skeletal surveillance and targeted bone-protective strategies, particularly in patients managed with long-term medical therapy.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
P289 - ECE_1810 - Differential skeletal recovery after surgical vs medical remission in Cushing’s disease: a 5-year observational study
Date Crossref
01/08/2026
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • University of Padua pays non établi dans la notice
    Université ou école supérieure
  • University of Padova Department of medicine—DIMED pays non établi dans la notice
    Université ou école supérieure
  • University Hospital of Padova Endocrinology Unit pays non établi dans la notice
    Université ou école supérieure

University of Padua, Department of medicine—DIMED — University of Padova et Endocrinology Unit — University Hospital of Padova.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.